Inheritance of susceptibility to multiple sclerosis

Current Opinion in Immunology

Volumn 10, Issue 6, 1998, Pages 697-703

  Sawcer, Stephen ^a   Goodfellow, Peter N ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

GENE MAPPING; GENETIC SUSCEPTIBILITY; HISTOCOMPATIBILITY GENE; HUMAN; INHERITANCE; MULTIPLE SCLEROSIS; REVIEW;

EID: 0032402940     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80091-5     Document Type: Article

References (121)

1. Davenport CB. Multiple sclerosis from the standpoint of geographic distribution and race. Arch Neurol Psychiatry. 8:1922;51-58.
2. Eichorst H. Uber infantile und hereditare multiple sclerose. Virchows Archiv. Infantile and hereditary multiple sclerosis 146:1896;173-193.
3. Hogancamp WE, Rodriguez M, Weinshenker BG. The epidemiology of multiple sclerosis. of outstanding interest Mayo Clin Proc. 72:1997;871-878 This paper provides a well written, comprehensive and up-to-date survey of the available genetic epidemiology relating to MS.
4. Sadovnick AD, Armstrong H, Rice GPA, Bulman D, Hashimoto L, Paty DW, Hashimoto SA, Warren S, Hader W, Murray TJ, et al. A population based study of multiple sclerosis in twins: updated. Ann Neurol. 33:1993;281-285.
5. Mumford CJ, Wood NW, Kellar-Wood HF, Thorpe J, Miller D, Compston DAS. The British Isles survey of multiple sclerosis in twins. Neurology. 44:1994;11-15.
6. Ebers GC, Sadovnick AD, Risch NJ. A genetic basis for familial aggregation in multiple sclerosis. The Canadian Collaborative Study Group. Nature. 377:1995;150-151.
7. Sadovnick AD, Ebers GC, Dyment DA, Risch NJ. Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group. Lancet. 347:1996;1728-1731.
8. Robertson NP, O'Riordan JI, Chataway J, Kingsley DPE, Miller DH, Clayton D, Compston DA. Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet. 349:1997;1587-1590.
9. Dean G, McLoughlin H, Brady R, Adelstein A, Tallett-Williams J. Multiple sclerosis among immigrants in Greater London. Brit Med J. 1:1976;861-864.
10. Kurtzke JF, Gudmundsson KR, Bergmann S. Multiple sclerosis in Iceland. Evidence of a post war epidemic. Neurology. 32:1982;143-150.
11. Jersild C, Svejgaard A, Fog T. HL-A antigens and multiple sclerosis. Lancet. 1:1972;1240-1241.
12. Winchester RJ, Ebers GC, Fu SM, Espinosa L, Zabriskie J, Kunkel HG. B-cell alloantigen Ag7a in multiple sclerosis. Lancet. 7939:1975;814.
13. Compston DAS, Batchelor JR, McDonald WI. B lymphocyte alloantigens associated with multiple sclerosis. Lancet. 7998:1976;1261-1265.
14. Hauser SL, Fleischnick E, Weiner H, Marcus D, Awdeh Z, Yunis E, Alper CA. Extended major histocompatibility complex haplotypes in patients with multiple sclerosis. Neurology. 39:1989;275-277.
15. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigen. 38:1991;1-15.
16. Haegert DG, Francis GS. HLA-DQ polymorphisms do not explain HLA class II associations with multiple sclerosis in two patient groups. Neurology. 43:1993;1207-1210.
17. Allen M, Sandberg-Wollheim M, Sjogren K, Erlich H, Petterson U, Gyllensten U. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles. Hum Immunol. 39:1994;41-48.
18. Sandberg-Wollheim M, Ciusani E, Salmaggi A, Pociot F. An evaluation of tumour necrosis factor microsatellites in genetic susceptibility to multiple sclerosis. Mult Scler. 1:1995;181-185.
19. Kirk CW, Droogan AG, Hawkins SA, McMillan SA, Nevin NC, Graham CA. Tumour necrosis factor microsatellites show association with multiple sclerosis. of special interest J Neurol Sci. 147:1997;21-25 This is a large study exploring the HLA association of MS; it concludes that associations seen with alleles from nearby markers such as that for TNF-α are probably just secondary to the established DR2 association.
20. Epplen C, Jäckel S, Santos EJM, D'Souza M, Poehlau D, Dotzauer B, Sindern E, Haupts M, Rüde KP, Weber F, et al. Genetic predisposition to multiple sclerosis as revealed by immunoprinting. of special interest Ann Neurol. 41:1997;341-352 The authors describe a large study exploring the HLA association of MS; they conclude that the established DR2 association is secondary to that resulting from an association with alleles of the TNF-α marker. This result is in contradiction to that claimed in [19].
21. Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER, Oksenberg JR, Lincoln R, Zhang DY, Banatao DR, et al. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. of special interest Hum Mol Genet. 7:1998;1229-1234 This study is an extension of the group's genome screen, that concentrates on the analysis of the HLA region. The authors find increased evidence supporting the notion that a susceptibility gene is encoded in the HLA region. The strongest effect seen in their population is with the DRB1 locus, leading the authors to conclude that this must therefore be the responsible gene - a claim which cannot be supported on the basis of their data.
22. Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. of outstanding interest Hum Mol Genet. 7:1998;1235-1237 This is a very important study, in which the authors definitively establish that the HLA haplotypes associated with MS in the Sardinian population are distinct. They also provide data and discussion which acknowledges that the contribution of the individual alleles within these haplotype cannot be conclusively determined.
23. Coraddu F, Sawcer S, Feakes R, Chataway J, Broadley S, Jones HB, Clayton D, Gray J, Smith S, Taylor C, et al. HLA conditioning in a multiple sclerosis genome screen. Neurogenetics. 1998;. in press.
24. Sadovnick AD, Baird PA. The familial nature of multiple sclerosis: age-corrected empiric recurrence risks for children and siblings of patients. Neurology. 38:1988;990-991.
25. Robertson NP, Fraser M, Deans J, Clayton D, Walker N, Compston DAS. Age adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain. 119:1996;449-455.
26. Carton H, Vlietinck R, Debruyne J, DeKeyser J, D'Hooghe MB, Loos R, Medaer R, Truyen L, Yee IM, Sadovnick AD. Risks of multiple sclerosis in relatives of patients in Flanders, Belgium. of special interest J Neurol Neurosurg Psychiatry. 62:1997;329-333 This is a large population-based study of familial recurrence risks in MS. Its results and implications do not differ in any substantial way from those found in previous similar studies, indicating as it does a significant familial incidence of the disease.
27. Risch N. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet. 46:1990;222-228.
28. Risch N. Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet. 46:1990;229-241.
29. Risch N. Linkage strategies for genetically complex traits. III. The effect of marker polymorphism on the analysis of affected relative pairs. Am J Hum Genet. 46:1990;242-253.
30. Sadovnick AD, Baird PA, Ward RH. Multiple sclerosis: updated risks for relatives. Am J Med Genet. 29:1988;533-541.
31. Morton NE. Sequential tests for the detection of linkage. Am J Hum Genet. 7:1955;277-318.
32. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J. The 1993-94 Genethon human genetic linkage map. Nat Genet. 7:1994;246-339.
33. Dib C, Faure S, Fizames C, Samson D, Dourot N, Vignal A, Millassean P, Marc S, Hazan J, Seboun E, et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature. 380:1996;152-154.
34. Weber JL, May PE. Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction. Am J Hum Genet. 44:1989;388-396.
35. Diehl SR, Ziegle J, Buck GA, Reynolds TR, Weber JL. Automated genotyping of human DNA polymorphisms [abstract]. Am J Hum Genet. 47:1990;A177.
36. Ziegle JS, Su Y, Corcoran KP, Nie L, Mayrand PE, Hoff LB, McBride LJ, Kronick MN, Diehl SR. Application of automated DNA sizing technology for genotyping microsatellite loci. Genomics. 14:1992;1026-1031.
37. Kruglyak L, Lander ES. Complete multipoint sib-pair analysis of qualitative and quantitative traits. Am J Hum Genet. 57:1995;439-454.
38. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet. 58:1996;1347-1363.
39. Kruglyak L, Lander ES. High-resolution genetic mapping of complex traits. Am J Hum Genet. 56:1995;1212-1223.
40. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 11:1995;241-247.
41. Sawcer SJ, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A. A genome screen in multiple sclerosis reveals susceptibility loci on chromosomes 6p21 and 17q22. Nat Genet. 13:1996;464-468.
42. Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, Pericak-Vance MA, Rimmler JB, Haynes CS, Roses AD, et al. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat Genet. 13:1996;469-471.
43. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C, Armstrong H, Cousin K, Bell RB, Hader W, et al. A full genome search in multiple sclerosis. Nat Genet. 13:1996;472-476.
44. Kuokkanen S, Gschwend M, Rioux JD, Daly MJ, Terwilliger JD, Tienari PJ, Wikström J, Palo J, Stein LD, Hudson TJ, et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. of outstanding interest Am J Hum Genet. 61:1997;1379-1387 This is the fourth whole-genome linkage screen to be completed in MS. Although the population studied is small it adds important data, increasing the evidence for linkage in several novel regions including chromosome 17q22 and 5cen. The study was based in a genetically isolated population - a factor which adds special interest to the results.
45. Sawcer SJ, Jones HB, Judge D, Visser F, Compston DAS, Goodfellow PN, Clayton D. Empirical genomewide significance levels established by whole genome simulations. Genet Epidemiol. 14:1997;223-229.
46. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
47. Sawcer SJ, Goodfellow PN, Compston DAS. The genetic analysis of multiple sclerosis. of outstanding interest Trends Genet. 13:1997;234-239 This paper reviews the methodological basis of sibling-pair studies, as well as the current state of knowledge regarding the disease.
48. Dyment DA, Sadnovich AD, Ebers GC. Genetics of multiple sclerosis. Hum Mol Genet. 6:1997;1693-1698.
49. Holmans P. Asymptotic properties of affected-sib-pair linkage analysis. Am J Hum Genet. 52:1993;362-374.
50. Ott J. Analysis of human genetic linkage. 1991;The John Hopkins University Press, Baltimore.
51. Jorde LB. Linkage disequilibrium as a gene-mapping tool. Am J Hum Genet. 56:1995;11-14.
52. Thompson EA, Neel JV. Alleleic disequilibrium and allele frequency distribution as a function of social and demographic history. of outstanding interest Am J Hum Genet. 60:1997;197-204 This paper addresses the effects of population growth on allele frequencies and linkage disequilibrium. It shows that, even without selection, a mutant allele can reach a high frequency in a growing population. This is important, as it indicates that linkage disequilibrium and founder effects will exist in Northern European populations as a consequence of their growth.
53. MacDonald ME, Novelletto A, Lin C, Tagle D, Barnes G, Bates G, Taylor S, Allitto B, Altherr M, Myers R, et al. The huntington's disease candidate region exhibits many different haplotypes. Nat Genet. 1:1992;99-103.
54. Morral N, Bertranpetit J, Estivill X, Nunes V, Casals T, Giménez J, Reis A, Varon-Mateeva R, Macek M Jr, Kalaydjieva L, et al. The origin of the major cystic fibrosis mutation (deltaF508) in european populations. Nat Genet. 7:1994;169-175.
55. Petrij-Bosch A, Peelen T, VanVliet M, VanEijk R, Olmer R, Drüsedau M, Hagervorst FB, Hageman S, Arts PJ, Ligtenberg MJ, et al. BRAC1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet. 17:1997;341-345.
56. Durham LK, Feingold E. Genome scanning for segments shared identical by descent among distant relatives in isolated populations. Am J Hum Genet. 61:1997;830-842.
57. Kruglyak L. What is significant in whole-genome linkage disequilibrium studies? of outstanding interest Amer J Hum Genet. 61:1997;810-812 This commentary addresses the difficulties of interpreting linkage disequilibrium findings and provides a clear description of the various confounding factors which can give rise to apparent linkage disequilibrium when none exists.
58. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet. 52:1993;506-516.
59. Spielman RS, Ewens WJ. The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet. 59:1996;983-989.
60. Barcellos LF, Klitz W, Field LL, Tobias R, Bowcock AM, Wilson R, Nelson MP, Nagatomi J, Thomson G. Association mapping of disease loci using a pooled DNA genomic screen. of outstanding interest Am J Hum Genet. 61:1997;734-747 This paper describes the DNA pooling method in detail and provides useful power calculations relating to this method.
61. Carmi R, Rokhlina T, Kwitek-Black AE, Elbedour K, Nishimura D, Stone E, Sheffield VC. Use of a DNA pooling strategy to identify a human obesity syndrome locus on chromosome 15. Hum Mol Genet. 4:1995;9-13.
62. Nystuen A, Benke PJ, Merren J, Stone EM, Sheffield V. A cerebellar ataxia locus identified by DNA pooling to search for linkage disequilibrium in an isolated population from the Cayman Islands. Hum Mol Genet. 5:1996;525-531.
63. Sheffield VC, Kraiem Z, Beck JC, Nishimura D, Stone EM, Salameh M, Sadeh O, Glaser M. Pendred syndrome maps to chromosome 7q21-34 and is caused by an intrinsic defect in thyroid iodine organification. Nat Genet. 12:1996;424-426.
64. Scott DA, Carmi R, Elbedour K, Yosefsberg S, Stone EM, Sheffield VC. An autosomal recessive nonsyndromic-hearing-loss locus identified by DNA pooling using two inbred Bedouin kindreds. Am J Hum Genet. 59:1996;385-391.
65. Taylor BA, Phillips SJ. Detection of obesity QTLs on mouse chromosomes 1 and 7 by selective DNA pooling. Genomics. 34:1996;389-398.
66. Schafer AJ, Hawkins JR. DNA variation and the future of human genetics. Nat Biotechnol. 16:1998;33-39.
67. Kruglyak L. The use of a genetic map of biallelic markers in linkage studies. of outstanding interest Nat Genet. 17:1997;21-24 This paper gives a clear account of the advantages of biallelic markers in genetics and provides power calculations indicating the relative effectiveness of such markers, as compared to microsatellites.
68. Bennett ST, Lucassen AM, Gough SCL, Powell EE, Undlien DE, Pritchard LE, Merriman ME, Kawaguchi Y, Dronsfield MJ, Pociot F, et al. Susceptibility to human type1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet. 9:1995;284-292.
69. Sundvall M, Jirholt J, Yang H-T, Jansson L, Engström A, Pettersson U, Holmdahl R. Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat Genet. 10:1995;313-317.
70. Encinas JA, Lees MB, Sobel RA, Symonowicz C, Greer JM, Shovlin CL, Weiner HL, Seidman CE, Seidman JG, Kuchroo VK. Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/J and B10.S mice. J Immunol. 157:1996;2186-2192.
71. Lorentzen JC, Andersson M, Issazadeh S, Dahlman I, Luthman H, Weissert R, Olsson T. Genetic analysis of inflammation, cytokine mRNA expression and disease course of relapsing experimental autoimmune encephalomyelitis in DA rats. J Neuroimmunol. 80:1997;31-37.
72. Croxford JL, O'Neill JK, Baker D. Polygenic control of experimental allergic encephalomyelitis in Biozzi ABH and BALB/c mice. J Neuroimmunol. 74:1997;205-211.
73. Bureau JF, Montagutelli X, Bihl F, Lefebvre S, Guenet JL, Brahic M. Mapping loci influencing the persistence of Theiler's virus in the murine central nervous system. Nat Genet. 5:1993;87-91.
74. Teuscher C, Rhein DM, Livingstone KD, Paynter RA, Doerge RW, Nicholson SM, Melvold RW. Evidence that Tmevd2 and eae3 may represent either a common locus or members of a gene complex controlling susceptibility to immunologically mediated demyelination in mice. J Immunol. 159:1997;4930-4934.
75. Bureau JF, Drescher KM, Pease LR, Vikoren T, Delcroix M, Zoecklein L, Brahic M, Rodriguez M. Chromosome 14 contains determinants that regulate susceptibility to Theiler's virue-induced demyelination in the mouse. Genetics. 148:1998;1941-1949.
76. Bahk YY, Kappel CA, Rasmussen G, Kim BS. Association between susceptibility to Theiler's virus-induced demyelination and T-cell receptor Jbeta1-Cbeta1 polymorphism rather than Vbeta deletion. J Virol. 71:1997;4181-4185.
77. Liu J, Marino MW, Wong G, Grail D, Dunn A, Bettadapura J, Slavin AJ, Old L, Bernard CC. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat Med. 4:1998;78-83.
78. DeLaConcha EG, Arroyo R, Crusius JB, Campillo JA, Martin C, VarelaDeSeijas E, Claveria LE, Fernandez-Arquero M. Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. J Neuroimmunol. 80:1997;172-178.
79. Saruhan-Direskeneli G, Esin S, Baykan-Kurt B, Ornek I, Vaughan R, Eraksoy M. HLA-DR and -DQ associations with multiple sclerosis in Turkey. Hum Immunol. 55:1997;59-65.
80. Barcellos LF, Thomson G, Carrington M, Schafer J, Begovich AB, Lin P, Xu XH, Min BQ, Marti D, Klitz W. Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese. JAMA. 278:1997;1256-1261.
81. Spurkland A, Celius EG, Knutsen I, Beiske A, Thorsby E, Vartdal F. The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer. Tissue Antigen. 50:1997;15-22.
82. Stewart GJ, Teutsch SM, Castle M, Heard RN, Bennetts BH. HLA-DR, -DQA1 and -DQB1 associations in Australian multiple sclerosis patients. Eur J Immunogenet. 24:1997;81-92.
83. Fogdell A, Olerup O, Fredrikson S, Verthern M, Hillert J. Linkage analysis of HLA class II genes in Swedish multiplex families with multiple sclerosis. Neurology. 48:1997;758-762.
84. Coraddu F, Reyes-Yanez MP, Parra A, Gray J, Smith SI, Taylor CJ, Compston DA. HLA associations with multiple sclerosis in the Canary Islands. of special interest J Neuroimmunol. 87:1998;130-135 This paper provides further evidence supporting the existence of novel HLA associations in Mediterranean populations.
85. Garcia-Merino A, Alper CA, Usuku K, Marcus-Bagley D, Lincoln R, Awdeh Z, Yunis EJ, Eisenbarth GS, Brink SJ, Hauser SL. Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion. Hum Immunol. 50:1996;11-21.
86. Huizinga TW, Westendrop RG, Bollen EL, Keijsers V, Brinkman BM, Langermans JA, Breedveld FC, Verweij CL, van der Gaer L, Dams L, et al. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol. 72:1997;149-153.
87. Ristori G, Carcassi C, Lai S, Fiori P, Cacciani A, Floris L, Montesperelli C, Di Giovanni S, Bottinelli C, Contu L, et al. HLA-DM polymorphisms do not associate with multiple sclerosis: an association study with analysis of myelin basic protein T cell specificity. J Neuroimmunol. 77:1997;181-184.
88. Hockertz MK, Paty DW, Beall SS. Susceptibility to relapsing-progressive multiple sclerosis is associated with inheritance of genes linked to the variable region of the TcR beta locus: use of affected family-based controls. Amer J Hum Genet. 62:1998;373-385.
89. Beall SS, Concannon P, Charmley P, McFarland HF, Gatti RA, Hood LE, McFarlin DE, Biddison WE. The germline repertoire of T-cell beta chain genes in patients with progressive multiple sclerosis. J Neuroimmunol. 21:1989;59-66.
90. Seboun E, Robinson MA, Doolittle TH. A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex. Cell. 57:1989;1095-1100.
91. Charmley P, Beall SS, Concannon P, Hood LE, Gatti RA. Further localisation of a multiple sclerosis susceptibility gene on chromosome 7q using a new T-cell receptor β chain polymorphism. J Neuroimmunol. 32:1991;231-240.
92. Beall SS, Biddison WE, McFarlin DE, McFarland H, Hood LE. Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175 kb region of the TCR V beta locus and the HLA class II genes. J Neuroimmunol. 45:1993;53-60.
93. Fugger L, Sandberg-Wollheim M, Morling N, Ryder LP, Svejgaard A. The germline repertoire of T-cell receptor beta chain genes in patients with relapsing remitting multiple sclerosis or optic neuritis. Immunogenetics. 31:1990;278-280.
94. Hillert J, Leng C, Olerup O. No association with germline T-cell receptor beta-chain gene alleles or haplotypes in Swedish patients with multiple sclerosis. J Neuroimmunol. 31:1991;141-147.
95. Lynch SG, Rose JW, Petajan JH, Stauffer D, Kamerath C, Leppert M. Discordance of T-cell receptor beta-chain genes in familial multiple sclerosis. Ann Neurol. 30:1991;402-410.
96. Vandevyver C, Buyse I, Philippaerts L, Ghabanbasani Z, Medaer R, Carton H, Cassiman JJ, Raus J. HLA and T-cell receptor polymorphisms in Belgian multiple sclerosis patients; no evidence for disease association with the T-cell receptor. J Neuroimmunol. 52:1994;25-32.
97. Droogan AG, Kirk CW, Hawkins SA, McMillan SA, Nevin NC, Graham CA. T-cell receptor alpha, beta, gamma and delta chain microsatellites show no association with multiple sclerosis. Neurology. 47:1996;1049-1053.
98. Wansen K, Pastinen T, Kuokkanen S, Wikstrom J, Palo J, Peltonen L, Tienari P. Immune system genes in multiple sclerosis: genetic association and linkage analyses on TCR beta, IGH, IFN-gamma and IL-1ra/IL-1 beta loci. J Neuroimmunol. 79:1997;29-36.
99. Feakes R, Chataway J, Sawcer S, Jones HB, Clayton D, Goodfellow PN, Compston A. Susceptibility to multiple sclerosis and the immunoglobulin heavy chain gene cluster. Ann Neurol. 1998;. in press.
100. Ligers A, He B, Fogdell-Hahn A, Olerup O, Hillert J. No linkage or association of a VNTR marker in the junction region of the immunoglobulin heavy chain genes in multiple sclerosis. Eur J Immunogenet. 24:1997;259-264.
101. Mycko MP, Kwinkowoski M, Tronczynska E, Szymanska B, Selmaj KW. Multiple sclerosis: the increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469. Ann Neurol. 44:1998;70-75.
102. Vanderbroeck K, Martino G, Marrosu M, Consiglio A, Zaffaroni M, Vaccargiu S, Franciotta D, Ruggeri M, Comi G, Grimaldi LM. Occurance and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis. J Neuroimmunol. 76:1997;189-192.
103. Reynolds WF, Chang E, Douer D, Ball ED, Kanda V. An allelic association implicates myeloperoxidase in the aetiology of acute promyelocytic leukaemia. Blood. 90:1997;2730-2737.
104. Nagra RM, Becher B, Tourtellote WW, Antel JP, Gold D, Paladino T, Smith RA, Nelson JR, Reynolds WF. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol. 78:1997;97-107.
105. Bennetts BH, Teutsch SM, Buhler MM, Heard RN, Stewart GJ. The CCR5 deletion mutation fails to protect against multiple sclerosis. Hum Immunol. 58:1997;52-59.
106. Tienari PJ, Kuokkanen S, Pastinen T, Wikström J, Sajantila A, Sandberg-Wollheim M, Pallo J, Peltonen L. Golli-MBP gene in multiple sclerosis susceptibility. J Neuroimmunol. 81:1998;158-167.
107. Nellemann LJ, Frederiksen J, Morling N. PCR typing of two short tandem repeat (STR) structures upstreams of the human myelin basic protein (MBP) gene; the genetic susceptibility in multiple sclerosis and monosymptomatic idiopathic optic neuritis in Danes. Mult Scler. 1:1995;186-189.
108. Price SE, Sharpe G, Boots A, Poutsma A, Mason C, James J, Hinks L, Thompson RJ. Role of myelin basic protein and proteolipid protein genes in multiple sclerosis: single strand conformation polymorphism analysis of the human sequences. Neuropathol Appl Neurobiol. 23:1997;457-467.
109. He B, Yang B, Lundahl J, Fredrikson S, Hillert J. The myelin basic protein gene in multiple sclerosis: identification of discrete alleles of a 1.3 kb tetranucleotide repeat sequence. Acta Neurol Scand. 97:1998;46-51.
110. Rodriguez D, DellaGaspera B, Zalc B, Hauw JJ, Fontaine B, Edan G, Clanet M, Dautingy A, Pham-Dinh D. Identification of a Val 145 lle substitution in the human myelin oligodendrocyte glycoprotein: lack of association with multiple sclerosis. Mult Scler. 3:1997;377-381.
111. Thompson RJ, Mason CR, Douglas AJ, Hinks LJ, Dwarswaard A, Price SE. Analysis of polymorphisms of the 2′,3′-cyclic nucleotide-3′-phosphodiesterase gene in patients with multiple sclerosis. Mult Scler. 2:1996;215-221.
112. He B, Xu C, Yang B, Landtblom AM, Fredrikson S, Hillert J. Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis. J Neuroimmunol. 86:1998;13-19.
113. Heward J, Gough SC. Genetic susceptibility to the development of autoimmune disease. Clin Sci (Colch). 93:1997;479-491.
114. Harding AE, Sweeney MG, Miller DH, Mumford CJ, Kellar-Wood H, Menard D, McDonald WI, Compston DA. Occurrence of multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain. 115:1992;979-989.
115. Riordan-Eva P, Sanders MD, Govan GG, Sweeney MG, DaCosta J, Harding AE. The clinical features of Leber's hereditary optic neuropathy defined by the presence of pathogenic mitochondrial DNA mutation. Brain. 118:1995;319-337.
116. Kellar-Wood H, Robertson N, Gorvan GG, Compston DAS. Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol. 36:1994;109-112.
117. Kalman B, Lublin FD, Alder H. Mitochondrial DNA mutations in multiple sclerosis. Mult Scler. 1:1995;32-36.
118. Nishimura M, Obayashi H, Ohta M, Uchiyama T, Hao Q, Saida T. No association of the 11778 mitochondrial DNA mutation and multiple sclerosis in Japan. Neurology. 45:1995;1333-1334.
119. Kalman B, Rodriguez-Valdez JL, Bosch U, Lubin FD. Screening for Leber's hereditary optic neuropathy associated mitochondrial DNA mutations in patients with prominent optic neuritis. Mult Scler. 2:1997;279-282.
120. Cock H, Mandler R, Ahmed W, Schapira AH. Neuromyelitis optica (Devic's syndrome): no association with the primary mitochondrial DNA mutations found in Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiat. 62:1997;85-87.
121. Leuzzi V, Carducci C, Lenza M, Salvetti M, Ristori G, DiGiovanni S, Torrini A. LHON mutations in Italian patients affected by multiple sclerosis. Acta Neurol Scand. 96:1997;145-148.